Transgene (France) Market Value
| TNG Stock | EUR 0.69 0.01 1.47% |
| Symbol | Transgene |
Transgene 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Transgene's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Transgene.
| 12/15/2024 |
| 03/15/2025 |
If you would invest 0.00 in Transgene on December 15, 2024 and sell it all today you would earn a total of 0.00 from holding Transgene SA or generate 0.0% return on investment in Transgene over 90 days. Transgene is related to or competes with Innate Pharma, Nanobiotix, Genfit, and AB Science. Transgene SA, a biotechnology company, designs, develops, and produces therapeutic vaccines and oncolytic viruses for th... More
Transgene Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Transgene's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Transgene SA upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.0259 | |||
| Maximum Drawdown | 17.24 | |||
| Value At Risk | (2.86) | |||
| Potential Upside | 2.9 |
Transgene Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Transgene's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Transgene's standard deviation. In reality, there are many statistical measures that can use Transgene historical prices to predict the future Transgene's volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.04) | |||
| Total Risk Alpha | 0.2563 | |||
| Treynor Ratio | (0.87) |
Transgene SA Backtested Returns
Transgene SA owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0304, which indicates the firm had a -0.0304 % return per unit of risk over the last 3 months. Transgene SA exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Transgene's Risk Adjusted Performance of (0.01), coefficient of variation of (6,622), and Variance of 5.85 to confirm the risk estimate we provide. The entity has a beta of 0.0533, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Transgene's returns are expected to increase less than the market. However, during the bear market, the loss of holding Transgene is expected to be smaller as well. At this point, Transgene SA has a negative expected return of -0.0674%. Please make sure to validate Transgene's variance, skewness, day typical price, as well as the relationship between the total risk alpha and daily balance of power , to decide if Transgene SA performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.26 |
Poor predictability
Transgene SA has poor predictability. Overlapping area represents the amount of predictability between Transgene time series from 15th of December 2024 to 29th of January 2025 and 29th of January 2025 to 15th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Transgene SA price movement. The serial correlation of 0.26 indicates that nearly 26.0% of current Transgene price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.26 | |
| Spearman Rank Test | -0.18 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Transgene SA lagged returns against current returns
Autocorrelation, which is Transgene stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Transgene's stock expected returns. We can calculate the autocorrelation of Transgene returns to help us make a trade decision. For example, suppose you find that Transgene has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Transgene regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Transgene stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Transgene stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Transgene stock over time.
Current vs Lagged Prices |
| Timeline |
Transgene Lagged Returns
When evaluating Transgene's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Transgene stock have on its future price. Transgene autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Transgene autocorrelation shows the relationship between Transgene stock current value and its past values and can show if there is a momentum factor associated with investing in Transgene SA.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Transgene Stock
Transgene financial ratios help investors to determine whether Transgene Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Transgene with respect to the benefits of owning Transgene security.